Trials / Completed
CompletedNCT04404608
Etiology of Lymphopenia in Covid19 Infection
Study of the Etiology of Lymphopenia in Covid19 Viral Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 172 (actual)
- Sponsor
- Dr Medhat Khafagy · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.
Detailed description
Each cohort will include 30 patients. Complete blood count in all patients will be done daily in all patients. Bone marrow aspiration cytology will be done in some selected patients especially those with lymphopenia less than 1000 per cubic mm. Correlation of the degree of lymphopenia with the status of the patients will be done. Also correlation will be done about the relation of recovery of lymphopenia and status of the patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Complete blood picture, bone marrow aspiration cytology | none except the regular routine investigations in such cases |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
- First posted
- 2020-05-27
- Last updated
- 2022-07-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04404608. Inclusion in this directory is not an endorsement.